{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T18:11:48Z","timestamp":1788372708060,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Klin Intensivmed Notfmed"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s00063-023-01093-w","type":"journal-article","created":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T13:03:24Z","timestamp":1701781404000},"page":"86-92","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Corticosteroids in sepsis and community-acquired pneumonia","Kortikosteroide bei Sepsis und ambulant erworbener Pneumonie"],"prefix":"10.1007","volume":"118","author":[{"given":"Amedeo","family":"Guzzardella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Motos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Vallverd\u00fa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,5]]},"reference":[{"key":"1093_CR1","doi-asserted-by":"publisher","first-page":"CD002243","DOI":"10.1002\/14651858.CD002243.pub3","volume":"2015","author":"D Annane","year":"2015","unstructured":"Annane\u00a0D, Bellissant\u00a0E, Bollaert\u00a0PE et\u00a0al (2015) Corticosteroids for treating sepsis. Cochrane Database Syst Rev 2015:CD2243. https:\/\/doi.org\/10.1002\/14651858.CD002243.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"1093_CR2","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1007\/s00134-017-4919-5","volume":"43","author":"D Annane","year":"2017","unstructured":"Annane\u00a0D, Pastores\u00a0SM, Rochwerg\u00a0B et al (2017) Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (part I): society of critical care medicine (SCCM) and European society of intensive care medicine (ESICM) 2017. Intensive Care Med 43:1751\u20131763. https:\/\/doi.org\/10.1007\/s00134-017-4919-5","journal-title":"Intensive Care Med"},{"key":"1093_CR3","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1056\/nejmoa1705716","volume":"378","author":"D Annane","year":"2018","unstructured":"Annane\u00a0D, Renault\u00a0A, Brun-Buisson\u00a0C et al (2018) Hydrocortisone plus fludrocortisone for adults with septic shock. N\u00a0Engl J Med 378:809\u2013818. https:\/\/doi.org\/10.1056\/nejmoa1705716","journal-title":"N Engl J Med"},{"key":"1093_CR4","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1001\/jama.288.7.862","volume":"288","author":"D Annane","year":"2002","unstructured":"Annane\u00a0D, S\u00e9bille\u00a0V, Charpentier\u00a0C et\u00a0al (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288:862\u2013871. https:\/\/doi.org\/10.1001\/jama.288.7.862","journal-title":"JAMA"},{"key":"1093_CR5","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1056\/NEJM199704103361506","volume":"336","author":"PJ Barnes","year":"1997","unstructured":"Barnes\u00a0PJ, Karin\u00a0M (1997) Nuclear factor-\u03baB\u2014a pivotal transcription factor in chronic inflammatory diseases. N\u00a0Engl J Med 336:1066\u20131071. https:\/\/doi.org\/10.1056\/NEJM199704103361506","journal-title":"N Engl J Med"},{"key":"1093_CR6","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/S0140-6736(14)62447-8","volume":"385","author":"CA Blum","year":"2015","unstructured":"Blum\u00a0CA, Nigro\u00a0N, Briel\u00a0M et al (2015) Adjunct prednisone therapy for patients with community-acquired pneumonia: a\u00a0multicentre, double-blind, randomised, placebo-controlled trial. Lancet 385:1511\u20131518. https:\/\/doi.org\/10.1016\/S0140-6736(14)62447-8","journal-title":"Lancet"},{"key":"1093_CR7","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1001\/jama.2010.2","volume":"303","author":"D Annane","year":"2010","unstructured":"COIITSS Study Investigators, Annane\u00a0D, Cariou\u00a0A et\u00a0al (2010) Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a\u00a0randomized controlled trial. JAMA 303:341\u2013348. https:\/\/doi.org\/10.1001\/jama.2010.2","journal-title":"JAMA"},{"key":"1093_CR8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2215145","author":"P-F Dequin","year":"2023","unstructured":"Dequin\u00a0P\u2011F, Meziani\u00a0F, Quenot\u00a0J\u2011P et al (2023) Hydrocortisone in severe community-acquired pneumonia. N\u00a0Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa2215145","journal-title":"N Engl J Med"},{"key":"1093_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-021-06506-y","author":"L Evans","year":"2021","unstructured":"Evans\u00a0L, Rhodes\u00a0A, Alhazzani\u00a0W et\u00a0al (2021) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. https:\/\/doi.org\/10.1007\/s00134-021-06506-y","journal-title":"Intensive Care Med"},{"key":"1093_CR10","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1001\/jamainternmed.2018.5849","volume":"179","author":"F Fang","year":"2019","unstructured":"Fang\u00a0F, Zhang\u00a0Y, Tang\u00a0J et al (2019) Association of corticosteroid treatment with outcomes in adult patients with sepsis: a\u00a0systematic review and meta-analysis. JAMA Intern Med 179:213\u2013223. https:\/\/doi.org\/10.1001\/jamainternmed.2018.5849","journal-title":"JAMA Intern Med"},{"key":"1093_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-017-1659-4","volume":"21","author":"B Gibbison","year":"2017","unstructured":"Gibbison\u00a0B, L\u00f3pez-L\u00f3pez\u00a0JA, Higgins\u00a0JPT et al (2017) Corticosteroids in septic shock: a\u00a0systematic review and network meta-analysis. Crit Care 21:1\u20138. https:\/\/doi.org\/10.1186\/s13054-017-1659-4","journal-title":"Crit Care"},{"key":"1093_CR12","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1073\/pnas.1210200110","volume":"110","author":"JE Goodwin","year":"2013","unstructured":"Goodwin\u00a0JE, Feng\u00a0Y, Velazquez\u00a0H, Sessa\u00a0WC (2013) Endothelial glucocorticoid receptor is required for protection against sepsis. Proc Natl Acad Sci U S\u00a0A 110:306\u2013311. https:\/\/doi.org\/10.1073\/pnas.1210200110","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1093_CR13","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1001\/jama.2016.10485","volume":"316","author":"AC Gordon","year":"2016","unstructured":"Gordon\u00a0AC, Mason\u00a0AJ, Thirunavukkarasu\u00a0N et\u00a0al (2016) Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA 316:509\u2013518. https:\/\/doi.org\/10.1001\/jama.2016.10485","journal-title":"JAMA"},{"key":"1093_CR14","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1164\/ajrccm\/144.3_pt_1.586","volume":"144","author":"LS Greos","year":"1991","unstructured":"Greos\u00a0LS, Vichyanond\u00a0P, Bloedow\u00a0DC et\u00a0al (1991) Methylprednisolone achieves greater concentrations in the lung than prednisolone: a\u00a0pharmacokinetic analysis. Am Rev Respir Dis 144:586\u2013592. https:\/\/doi.org\/10.1164\/ajrccm\/144.3_pt_1.586","journal-title":"Am Rev Respir Dis"},{"key":"1093_CR15","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1001\/jama.2016.14799","volume":"316","author":"D Keh","year":"2016","unstructured":"Keh\u00a0D, Trips\u00a0E, Marx\u00a0G et\u00a0al (2016) Effect of hydrocortisone on development of shock among patients with severe sepsis the HYPRESS randomized clinical trial. JAMA 316:1775\u20131785. https:\/\/doi.org\/10.1001\/jama.2016.14799","journal-title":"JAMA"},{"key":"1093_CR16","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1097\/00003246-199507000-00021","volume":"23","author":"R Lefering","year":"1995","unstructured":"Lefering\u00a0R, Neugebauer\u00a0EA (1995) Steroid controversy in sepsis and septic shock: a\u00a0meta-analysis. Crit Care Med 23:1294\u20131303. https:\/\/doi.org\/10.1097\/00003246-199507000-00021","journal-title":"Crit Care Med"},{"key":"1093_CR17","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1097\/CCM.0b013e31817603ba","volume":"36","author":"PE Marik","year":"2008","unstructured":"Marik\u00a0PE, Pastores\u00a0SM, Annane\u00a0D et\u00a0al (2008) Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American college of critical care medicine. Crit Care Med 36:1937\u20131949. https:\/\/doi.org\/10.1097\/CCM.0b013e31817603ba","journal-title":"Crit Care Med"},{"key":"1093_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-023-07033-8","author":"I Martin-Loeches","year":"2023","unstructured":"Martin-Loeches\u00a0I, Torres\u00a0A, Nagavci\u00a0B et al (2023) ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of severe community-acquired pneumonia. Intensive Care Med. https:\/\/doi.org\/10.1007\/s00134-023-07033-8","journal-title":"Intensive Care Med"},{"key":"1093_CR19","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s00134-022-06684-3","volume":"48","author":"GU Meduri","year":"2022","unstructured":"Meduri\u00a0GU, Shih\u00a0MC, Bridges\u00a0L et al (2022) Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia. Intensive Care Med 48:1009\u20131023. https:\/\/doi.org\/10.1007\/s00134-022-06684-3","journal-title":"Intensive Care Med"},{"key":"1093_CR20","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(11)60607-7","volume":"377","author":"SCA Meijvis","year":"2011","unstructured":"Meijvis\u00a0SCA, Hardeman\u00a0H, Remmelts\u00a0HHF et al (2011) Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a\u00a0randomised, double-blind, placebo-controlled trial. Lancet 377:2023\u20132030. https:\/\/doi.org\/10.1016\/S0140-6736(11)60607-7","journal-title":"Lancet"},{"key":"1093_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nano10112301","volume":"10","author":"R Molinaro","year":"2020","unstructured":"Molinaro\u00a0R, Pasto\u00a0A, Taraballi\u00a0F et al (2020) Biomimetic nanoparticles potentiate the anti-inflammatory properties of dexamethasone and reduce the cytokine storm syndrome: an additional weapon against COVID-19? Nanomaterials 10:1\u201312. https:\/\/doi.org\/10.3390\/nano10112301","journal-title":"Nanomaterials"},{"key":"1093_CR22","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1007\/s00134-018-5332-4","volume":"44","author":"G Moreno","year":"2018","unstructured":"Moreno\u00a0G, Rodr\u00edguez\u00a0A, Reyes\u00a0LF et\u00a0al (2018) Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a\u00a0propensity score matching study. Intensive Care Med 44:1470\u20131482. https:\/\/doi.org\/10.1007\/s00134-018-5332-4","journal-title":"Intensive Care Med"},{"key":"1093_CR23","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","volume":"384","author":"P Horby","year":"2021","unstructured":"RECOVERY Collaborative Group, Horby\u00a0P, Lim\u00a0WS et al (2021) Dexamethasone in hospitalized patients with Covid-19. N\u00a0Engl J Med 384:693\u2013704. https:\/\/doi.org\/10.1056\/NEJMoa2021436","journal-title":"N Engl J Med"},{"key":"1093_CR24","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s00134-018-5197-6","volume":"44","author":"SL Ryg\u00e5rd","year":"2018","unstructured":"Ryg\u00e5rd\u00a0SL, Butler\u00a0E, Granholm\u00a0A et al (2018) Low-dose corticosteroids for adult patients with septic shock: a\u00a0systematic review with meta-analysis and trial sequential analysis. Intensive Care Med 44:1003\u20131016. https:\/\/doi.org\/10.1007\/s00134-018-5197-6","journal-title":"Intensive Care Med"},{"key":"1093_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/eme08100","volume":"8","author":"M Shankar-Hari","year":"2021","unstructured":"Shankar-Hari\u00a0M, Santhakumaran\u00a0S, Prevost\u00a0AT et al (2021) Defining phenotypes and treatment effect heterogeneity to inform acute respiratory distress syndrome and sepsis trials: secondary analyses of three RCTs. Efficacy Mech Eval 8:1\u2013104. https:\/\/doi.org\/10.3310\/eme08100","journal-title":"Efficacy Mech Eval"},{"key":"1093_CR26","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer\u00a0M, Deutschman\u00a0CS, Seymour\u00a0C et al (2016) The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 315:801\u2013810. https:\/\/doi.org\/10.1001\/jama.2016.0287","journal-title":"JAMA"},{"key":"1093_CR27","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1164\/rccm.200905-0808OC","volume":"181","author":"D Snijders","year":"2010","unstructured":"Snijders\u00a0D, Daniels\u00a0JMA, de Graaff\u00a0CS et al (2010) Efficacy of corticosteroids in community-acquired pneumonia: a\u00a0randomized double-blinded clinical trial. Am J Respir Crit Care Med 181:975\u2013982. https:\/\/doi.org\/10.1164\/rccm.200905-0808OC","journal-title":"Am J Respir Crit Care Med"},{"key":"1093_CR28","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa071366","volume":"358","author":"CL Sprung","year":"2008","unstructured":"Sprung\u00a0CL, Annane\u00a0D, Keh\u00a0D et\u00a0al (2008) Hydrocortisone therapy for patients with septic shock. N\u00a0Engl J Med 358:111\u2013124. https:\/\/doi.org\/10.1056\/NEJMoa071366","journal-title":"N Engl J Med"},{"key":"1093_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-016-1511-2","volume":"20","author":"S Tongyoo","year":"2016","unstructured":"Tongyoo\u00a0S, Permpikul\u00a0C, Mongkolpun\u00a0W et al (2016) Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: results of a\u00a0randomized controlled trial. Crit Care 20:1\u201311. https:\/\/doi.org\/10.1186\/s13054-016-1511-2","journal-title":"Crit Care"},{"key":"1093_CR30","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1001\/jama.2015.88","volume":"313","author":"A Torres","year":"2015","unstructured":"Torres\u00a0A, Sibila\u00a0O, Ferrer\u00a0M et al (2015) Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a\u00a0randomized clinical trial. JAMA 313:677\u2013686. https:\/\/doi.org\/10.1001\/jama.2015.88","journal-title":"JAMA"},{"key":"1093_CR31","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1056\/nejmoa1705835","volume":"378","author":"B Venkatesh","year":"2018","unstructured":"Venkatesh\u00a0B, Finfer\u00a0S, Cohen\u00a0J et\u00a0al (2018) Adjunctive glucocorticoid therapy in patients with septic shock. N\u00a0Engl J Med 378:797\u2013808. https:\/\/doi.org\/10.1056\/nejmoa1705835","journal-title":"N Engl J Med"},{"key":"1093_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1183\/13993003.02535-2020","volume":"58","author":"E Wittermans","year":"2021","unstructured":"Wittermans\u00a0E, Vestjens\u00a0SMT, Spoorenberg\u00a0SMC et al (2021) Adjunctive treatment with oral dexamethasone in non-ICU patients hospitalised with community-acquired pneumonia: a\u00a0randomised clinical trial. Eur Respir\u00a0J 58:1\u201310. https:\/\/doi.org\/10.1183\/13993003.02535-2020","journal-title":"Eur Respir J"}],"container-title":["Medizinische Klinik - Intensivmedizin und Notfallmedizin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-023-01093-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00063-023-01093-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-023-01093-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T15:02:18Z","timestamp":1703084538000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00063-023-01093-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":32,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["1093"],"URL":"https:\/\/doi.org\/10.1007\/s00063-023-01093-w","relation":{},"ISSN":["2193-6218","2193-6226"],"issn-type":[{"value":"2193-6218","type":"print"},{"value":"2193-6226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"21 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A.\u00a0Guzzardella, A.\u00a0Motos, J.\u00a0Vallverd\u00fa and A.\u00a0Torres declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The supplement containing this article is not sponsored by industry.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}